Home > Search Clinical Trials > All > Trial Details

Clinical Trial Details

GOG 212 A Randomized Phase III of Maintenance Chemotherapy Comparing 12 Monthly Cycles of Single Agent Paclitaxel or CT-2103 VS No Treatment Until Documented Relapse in Women with Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer Who Achieve a Complete Clinical Response to Primary Platinum/Taxane Chemotherapy Clinical Trial ( IRB ) #: 11-009-3.2 Title: GOG 212 A Randomized Phase III of Maintenance Chemotherapy Comparing 12 Monthly Cycles of Single Agent Paclitaxel or CT-2103 VS No Treatment Until Documented Relapse in Women with Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer Who Achieve a Complete Clinical Response to Primary Platinum/Taxane Chemotherapy Principal Investigator: Dr. Molly Brewer Description: Study description not available Classification:   Cancer - Female Reproductive   Cancer - General Eligibility Criteria: Check with study contact How to Contact: Quratulain Ali. Telephone: 860-679-7648. Email: Qali@uchc.edu Enrollment Status/Comments: Enrolling/recruiting. For current recruitment status, please check with study contact.